APO Research
Talk to an analyst

APO RESEARCH · REPORT

Whole Exome Sequencing

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.

While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.

Selected research

Market Outlook & Growth Opportunities

Global Whole Exome Sequencing Market Outlook and Growth Opportunities 2026

2 January 2026194 pages

Choose your research edition.

Industry ResearchWhole Exome Sequencing Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal Whole Exome Sequencing Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal Whole Exome Sequencing Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Whole Exome Sequencing Market Outlook and Growth Opportunities 2026194 pages · $4,250 USDMarket Analysis & ForecastGlobal Whole Exome Sequencing Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

Exome sequencing is a capture based method developed to identify variants in the coding region of genes which affect protein function. While exome capture methods using PCR, hybrid capture and molecular inversion probes exist, the most common and efficient strategies are in-solution capture methods. In-solution capture utilizes pools of oligonucleotides or probes bound to magnetic beads, whose sequence has been designed to hybridize to exon regions. After binding to genomic DNA, these probes are pulled down and washed, allowing exon regions to be selectively sequenced.

While there are approximately 180,000 exons in the human genome, constituting less than 2% of total sequence, the exome contains ~80-90% of known disease causing variants making it a cost-effective alternative to whole genome sequencing. When performing exome-seq, users should not only consider average on-target coverage but also the local coverage of particular sites of interest. When choosing between exome and whole genome sequencing (WGS), consider that exome sequencing has the advantage that oligonucleotides are designed to particular genomic regions where typical coverage with WGS is not enough for SNP calling. It is also more affordable enabling the analysis of more individuals and populations. With WGS, you can detect variants in regions not covered by exome capture allowing or the identification of structural and non-coding variants associated with disease.

The major players in global Whole Exome Sequencing market include Illumina, Thermofisher, Roche, etc. The top 3 players occupy about 45% shares of the global market. North America and Europe are main markets, they occupy about 70% of the global market. Illumina TruSeq Exome and Roche Nimblegen SeqCap are main types, with a share about 55%. Mendelian Disease and Rare Syndrome Gene Discovery are the main application, which hold a share about 40%.

Read the full market overview

This report provides an overview of the global Whole Exome Sequencing market in terms of revenue and gross margin, analyzing global market trends using historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Whole Exome Sequencing and market revenue by major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Whole Exome Sequencing revenue, market share, and industry ranking for the main companies for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

Across the 2021-2026 period, the analysis compares revenue growth and profitability profiles by company, distinguishing participants with sustained expansion from those with more cyclical performance, and relates these patterns to differences in regional exposure, product portfolios, and application focus in the global Whole Exome Sequencing market.

Whole Exome Sequencing Segment by Company

Illumina

Thermo Fisher

Roche

Angilent

Eurofins

Sengenics

Ambry

Macrogen

BGI

Novo Gene

Whole Exome Sequencing Segment by Type

Agilent HaloPlex

Agilent SureSelect

Agilent SureSelect QXT

Illumina TruSeq Exome

Roche Nimblegen SeqCap

MYcroarray MYbaits

Whole Exome Sequencing Segment by Application

Correlation Research of Normal Human

Mendelian Disease and Rare Syndrome Gene Discovery

The Research of Complex Diseases

Mouse Exome Sequencing

Whole Exome Sequencing Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global Whole Exome Sequencing status and future forecast, involving, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the Whole Exome Sequencing key companies, revenue, market share, and recent developments.

3. To split the Whole Exome Sequencing breakdown data by regions, type, companies, and application.

4. To analyze the global and key regions Whole Exome Sequencing market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Whole Exome Sequencing significant trends, drivers, influence factors in global and regions.

6. To analyze Whole Exome Sequencing competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Whole Exome Sequencing market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Whole Exome Sequencing and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Whole Exome Sequencing.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, global total market size.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Whole Exome Sequencing industry.

Chapter 3: Detailed analysis of Whole Exome Sequencing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales value of Whole Exome Sequencing in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of key country in the world.

Chapter 7: Sales value of Whole Exome Sequencing in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including revenue, gross margin, product introduction, recent development, etc.

Chapter 9: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Whole Exome Sequencing Industry Trends Table 2. Whole Exome Sequencing Industry Drivers Table 3. Whole Exome Sequencing Industry Opportunities and Challenges Table 4. Whole Exome Sequencing Industry Restraints Table 5. Global Whole Exome Sequencing Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Whole Exome Sequencing Revenue Share by Company (2021-2026) Table 7. Global Whole Exome Sequencing Company Ranking, (2024-2026) & (US$ Million) Table 8. Global Whole Exome Sequencing Key Company Manufacturing Base & Headquarters Table 9. Global Whole Exome Sequencing Company, Product Type & Application Table 10. Global Whole Exome Sequencing Company Establishment Date Table 11. Global Company Market Concentration Ratio (CR5 and HHI) Table 12. Global Whole Exome Sequencing by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 13. Mergers & Acquisitions, Expansion Table 14. Significant Companies of Agilent HaloPlex Table 15. Significant Companies of Agilent SureSelect Table 16. Significant Companies of Agilent SureSelect QXT Table 17. Significant Companies of Illumina TruSeq Exome Table 18. Significant Companies of Roche Nimblegen SeqCap Table 19. Significant Companies of MYcroarray MYbaits Table 20. Global Whole Exome Sequencing Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 21. Global Whole Exome Sequencing Sales Value by Type (2021-2026) & (US$ Million) Table 22. Global Whole Exome Sequencing Sales Value by Type (2027-2032) & (US$ Million) Table 23. Global Whole Exome Sequencing Sales Value Share by Type (2021-2026) Table 24. Global Whole Exome Sequencing Sales Value Share by Type (2027-2032) Table 25. Significant Companies of Correlation Research of Normal Human Table 26. Significant Companies of Mendelian Disease and Rare Syndrome Gene Discovery Table 27. Significant Companies of The Research of Complex Diseases Table 28. Significant Companies of Mouse Exome Sequencing Table 29. Global Whole Exome Sequencing Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 30. Global Whole Exome Sequencing Sales Value by Application (2021-2026) & (US$ Million) Table 31. Global Whole Exome Sequencing Sales Value by Application (2027-2032) & (US$ Million) Table 32. Global Whole Exome Sequencing Sales Value Share by Application (2021-2026) Table 33. Global Whole Exome Sequencing Sales Value Share by Application (2027-2032) Table 34. Global Whole Exome Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 35. Global Whole Exome Sequencing Sales Value by Region (2021-2026) & (US$ Million) Table 36. Global Whole Exome Sequencing Sales Value Share by Region (2021-2026) Table 37. Global Whole Exome Sequencing Sales Value by Region (2027-2032) & (US$ Million) Table 38. Global Whole Exome Sequencing Sales Value Share by Region (2027-2032) Table 39. Global Whole Exome Sequencing Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 40. Global Whole Exome Sequencing Sales Value by Country (2021-2026) & (US$ Million) Table 41. Global Whole Exome Sequencing Sales Value Market Share by Country (2021-2026) Table 42. Global Whole Exome Sequencing Sales Value by Country (2027-2032) & (US$ Million) Table 43. Global Whole Exome Sequencing Sales Value Market Share by Country (2027-2032) Table 44. Illumina Company Information Table 45. Illumina Business Overview Table 46. Illumina Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 47. Illumina Whole Exome Sequencing Product Portfolio Table 48. Illumina Recent Development Table 49. Thermo Fisher Company Information Table 50. Thermo Fisher Business Overview Table 51. Thermo Fisher Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 52. Thermo Fisher Whole Exome Sequencing Product Portfolio Table 53. Thermo Fisher Recent Development Table 54. Roche Company Information Table 55. Roche Business Overview Table 56. Roche Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 57. Roche Whole Exome Sequencing Product Portfolio Table 58. Roche Recent Development Table 59. Angilent Company Information Table 60. Angilent Business Overview Table 61. Angilent Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 62. Angilent Whole Exome Sequencing Product Portfolio Table 63. Angilent Recent Development Table 64. Eurofins Company Information Table 65. Eurofins Business Overview Table 66. Eurofins Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 67. Eurofins Whole Exome Sequencing Product Portfolio Table 68. Eurofins Recent Development Table 69. Sengenics Company Information Table 70. Sengenics Business Overview Table 71. Sengenics Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 72. Sengenics Whole Exome Sequencing Product Portfolio Table 73. Sengenics Recent Development Table 74. Ambry Company Information Table 75. Ambry Business Overview Table 76. Ambry Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 77. Ambry Whole Exome Sequencing Product Portfolio Table 78. Ambry Recent Development Table 79. Macrogen Company Information Table 80. Macrogen Business Overview Table 81. Macrogen Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 82. Macrogen Whole Exome Sequencing Product Portfolio Table 83. Macrogen Recent Development Table 84. BGI Company Information Table 85. BGI Business Overview Table 86. BGI Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 87. BGI Whole Exome Sequencing Product Portfolio Table 88. BGI Recent Development Table 89. Novo Gene Company Information Table 90. Novo Gene Business Overview Table 91. Novo Gene Whole Exome Sequencing Revenue (US$ Million) and Gross Margin (2021-2026) Table 92. Novo Gene Whole Exome Sequencing Product Portfolio Table 93. Novo Gene Recent Development Table 94. Research Programs/Design for This Report Table 95. Authors List of This Report Table 96. Secondary Sources Table 97. Primary Sources List of Figures Figure 1. Whole Exome Sequencing Product Image Figure 2. Global Whole Exome Sequencing Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Whole Exome Sequencing Market Size (2021-2032) & (US$ Million) Figure 4. Global Whole Exome Sequencing Company Revenue Ranking in 2025 (US$ Million) Figure 5. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 6. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 7. Agilent HaloPlex Image Figure 8. Agilent SureSelect Image Figure 9. Agilent SureSelect QXT Image Figure 10. Illumina TruSeq Exome Image Figure 11. Roche Nimblegen SeqCap Image Figure 12. MYcroarray MYbaits Image Figure 13. Global Whole Exome Sequencing Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 14. Global Whole Exome Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 15. Global Whole Exome Sequencing Sales Value Share by Type (2021-2032) Figure 16. Correlation Research of Normal Human Image Figure 17. Mendelian Disease and Rare Syndrome Gene Discovery Image Figure 18. The Research of Complex Diseases Image Figure 19. Mouse Exome Sequencing Image Figure 20. Global Whole Exome Sequencing Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global Whole Exome Sequencing Sales Value Share 2021 VS 2025 VS 2032 Figure 22. Global Whole Exome Sequencing Sales Value Share by Application (2021-2032) Figure 23. Global Whole Exome Sequencing Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 24. Global Whole Exome Sequencing Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 25. North America Whole Exome Sequencing Sales Value (2021-2032) & (US$ Million) Figure 26. North America Whole Exome Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 27. Europe Whole Exome Sequencing Sales Value (2021-2032) & (US$ Million) Figure 28. Europe Whole Exome Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 29. Asia-Pacific Whole Exome Sequencing Sales Value (2021-2032) & (US$ Million) Figure 30. Asia-Pacific Whole Exome Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 31. South America Whole Exome Sequencing Sales Value (2021-2032) & (US$ Million) Figure 32. South America Whole Exome Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Middle East & Africa Whole Exome Sequencing Sales Value (2021-2032) & (US$ Million) Figure 34. Middle East & Africa Whole Exome Sequencing Sales Value Share by Country (%), 2025 VS 2032 Figure 35. USA Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 36. USA Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 37. USA Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 38. Canada Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 39. Canada Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 40. Canada Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 41. Mexico Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. Mexico Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. Mexico Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Germany Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Germany Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Germany Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. France Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. France Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. France Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. U.K. Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. U.K. Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. U.K. Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. Italy Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. Italy Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. Italy Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. Spain Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. Spain Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. Spain Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Russia Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Russia Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Russia Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Netherlands Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Netherlands Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Netherlands Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Nordic Countries Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Nordic Countries Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Nordic Countries Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. China Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. China Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. China Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Japan Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Japan Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Japan Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. South Korea Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. South Korea Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. South Korea Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. India Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. India Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. India Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. Australia Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. Australia Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. Australia Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. Southeast Asia Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. Southeast Asia Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. Southeast Asia Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Brazil Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Brazil Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Brazil Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Argentina Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Argentina Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Argentina Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Chile Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Chile Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Chile Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Colombia Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Colombia Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Colombia Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Peru Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Peru Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Peru Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Saudi Arabia Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Saudi Arabia Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Saudi Arabia Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Israel Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Israel Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Israel Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. UAE Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. UAE Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. UAE Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Turkey Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Turkey Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Turkey Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. Iran Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. Iran Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. Iran Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Egypt Whole Exome Sequencing Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Egypt Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Egypt Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Years Considered Figure 120. Research Process Figure 121. Key Executives Interviewed

Scope & coverage.

Types
  • Agilent HaloPlex
  • Agilent SureSelect
  • Agilent SureSelect QXT
  • Illumina TruSeq Exome
  • Roche Nimblegen SeqCap
  • MYcroarray MYbaits
Applications
  • Correlation Research of Normal Human
  • Mendelian Disease and Rare Syndrome Gene Discovery
  • The Research of Complex Diseases
  • Mouse Exome Sequencing
Companies covered
  • Illumina
  • Thermo Fisher
  • Roche
  • Angilent
  • Eurofins
  • Sengenics
  • Ambry
  • Macrogen
  • BGI
  • Novo Gene

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Whole Exome Sequencing Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Whole Exome Sequencing Market Size (2021-2032)
  4. 1.4 Assumptions and Limitations
  5. 1.5 Study Goals and Objectives
2 Whole Exome Sequencing Market Dynamics
  1. 2.1 Whole Exome Sequencing Industry Trends
  2. 2.2 Whole Exome Sequencing Industry Drivers
  3. 2.3 Whole Exome Sequencing Industry Opportunities and Challenges
  4. 2.4 Whole Exome Sequencing Industry Restraints
3 Whole Exome Sequencing Market by Company
  1. 3.1 Global Whole Exome Sequencing Company Revenue Ranking in 2025
  2. 3.2 Global Whole Exome Sequencing Revenue by Company (2021-2026)
  3. 3.3 Global Whole Exome Sequencing Company Ranking (2024-2026)
  4. 3.4 Global Whole Exome Sequencing Company Manufacturing Base and Headquarters
  5. 3.5 Global Whole Exome Sequencing Company Product Type and Application
  6. 3.6 Global Whole Exome Sequencing Company Establishment Date
  7. 3.7 Market Competitive Analysis
  8. 3.7.1 Global Whole Exome Sequencing Market Concentration Ratio (CR5 and HHI)
  9. 3.7.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  10. 3.7.3 2025 Whole Exome Sequencing Tier 1, Tier 2, and Tier 3 Companies
  11. 3.8 Mergers and Acquisitions Expansion
4 Whole Exome Sequencing Market by Type
  1. 4.1 Whole Exome Sequencing Type Introduction
  2. 4.1.1 Agilent HaloPlex
  3. 4.1.2 Agilent SureSelect
  4. 4.1.3 Agilent SureSelect QXT
  5. 4.1.4 Illumina TruSeq Exome
  6. 4.1.5 Roche Nimblegen SeqCap
  7. 4.1.6 MYcroarray MYbaits
  8. 4.2 Global Whole Exome Sequencing Sales Value by Type
  9. 4.2.1 Global Whole Exome Sequencing Sales Value by Type (2021 VS 2025 VS 2032)
  10. 4.2.2 Global Whole Exome Sequencing Sales Value by Type (2021-2032)
  11. 4.2.3 Global Whole Exome Sequencing Sales Value Share by Type (2021-2032)
5 Whole Exome Sequencing Market by Application
  1. 5.1 Whole Exome Sequencing Application Introduction
  2. 5.1.1 Correlation Research of Normal Human
  3. 5.1.2 Mendelian Disease and Rare Syndrome Gene Discovery
  4. 5.1.3 The Research of Complex Diseases
  5. 5.1.4 Mouse Exome Sequencing
  6. 5.2 Global Whole Exome Sequencing Sales Value by Application
  7. 5.2.1 Global Whole Exome Sequencing Sales Value by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Whole Exome Sequencing Sales Value by Application (2021-2032)
  9. 5.2.3 Global Whole Exome Sequencing Sales Value Share by Application (2021-2032)
6 Whole Exome Sequencing Regional Value Analysis
  1. 6.1 Global Whole Exome Sequencing Sales Value by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Whole Exome Sequencing Sales Value by Region (2021-2032)
  3. 6.2.1 Global Whole Exome Sequencing Sales Value by Region: 2021-2026
  4. 6.2.2 Global Whole Exome Sequencing Sales Value by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Whole Exome Sequencing Sales Value (2021-2032)
  7. 6.3.2 North America Whole Exome Sequencing Sales Value Share by Country, 2025 VS 2032
  8. 6.4 Europe
  9. 6.4.1 Europe Whole Exome Sequencing Sales Value (2021-2032)
  10. 6.4.2 Europe Whole Exome Sequencing Sales Value Share by Country, 2025 VS 2032
  11. 6.5 Asia-Pacific
  12. 6.5.1 Asia-Pacific Whole Exome Sequencing Sales Value (2021-2032)
  13. 6.5.2 Asia-Pacific Whole Exome Sequencing Sales Value Share by Country, 2025 VS 2032
  14. 6.6 South America
  15. 6.6.1 South America Whole Exome Sequencing Sales Value (2021-2032)
  16. 6.6.2 South America Whole Exome Sequencing Sales Value Share by Country, 2025 VS 2032
  17. 6.7 Middle East & Africa
  18. 6.7.1 Middle East & Africa Whole Exome Sequencing Sales Value (2021-2032)
  19. 6.7.2 Middle East & Africa Whole Exome Sequencing Sales Value Share by Country, 2025 VS 2032
7 Whole Exome Sequencing Country-level Value Analysis
  1. 7.1 Global Whole Exome Sequencing Sales Value by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Whole Exome Sequencing Sales Value by Country (2021-2032)
  3. 7.2.1 Global Whole Exome Sequencing Sales Value by Country (2021-2026)
  4. 7.2.2 Global Whole Exome Sequencing Sales Value by Country (2027-2032)
  5. 7.3 USA
  6. 7.3.1 USA Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  7. 7.3.2 USA Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  8. 7.3.3 USA Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  9. 7.4 Canada
  10. 7.4.1 Canada Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  11. 7.4.2 Canada Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  12. 7.4.3 Canada Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  13. 7.5 Mexico
  14. 7.5.1 Mexico Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  15. 7.5.2 Mexico Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  16. 7.5.3 Mexico Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  17. 7.6 Germany
  18. 7.6.1 Germany Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Germany Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Germany Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  21. 7.7 France
  22. 7.7.1 France Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  23. 7.7.2 France Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  24. 7.7.3 France Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  25. 7.8 U.K.
  26. 7.8.1 U.K. Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  27. 7.8.2 U.K. Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  28. 7.8.3 U.K. Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  29. 7.9 Italy
  30. 7.9.1 Italy Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  31. 7.9.2 Italy Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  32. 7.9.3 Italy Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  33. 7.10 Spain
  34. 7.10.1 Spain Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  35. 7.10.2 Spain Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  36. 7.10.3 Spain Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  37. 7.11 Russia
  38. 7.11.1 Russia Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  39. 7.11.2 Russia Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  40. 7.11.3 Russia Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  41. 7.12 Netherlands
  42. 7.12.1 Netherlands Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  43. 7.12.2 Netherlands Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  44. 7.12.3 Netherlands Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  45. 7.13 Nordic Countries
  46. 7.13.1 Nordic Countries Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  47. 7.13.2 Nordic Countries Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  48. 7.13.3 Nordic Countries Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  49. 7.14 China
  50. 7.14.1 China Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  51. 7.14.2 China Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  52. 7.14.3 China Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  53. 7.15 Japan
  54. 7.15.1 Japan Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  55. 7.15.2 Japan Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  56. 7.15.3 Japan Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  57. 7.16 South Korea
  58. 7.16.1 South Korea Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  59. 7.16.2 South Korea Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  60. 7.16.3 South Korea Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  61. 7.17 India
  62. 7.17.1 India Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  63. 7.17.2 India Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  64. 7.17.3 India Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  65. 7.18 Australia
  66. 7.18.1 Australia Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  67. 7.18.2 Australia Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  68. 7.18.3 Australia Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  69. 7.19 Southeast Asia
  70. 7.19.1 Southeast Asia Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  71. 7.19.2 Southeast Asia Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  72. 7.19.3 Southeast Asia Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  73. 7.20 Brazil
  74. 7.20.1 Brazil Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  75. 7.20.2 Brazil Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  76. 7.20.3 Brazil Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  77. 7.21 Argentina
  78. 7.21.1 Argentina Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  79. 7.21.2 Argentina Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  80. 7.21.3 Argentina Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  81. 7.22 Chile
  82. 7.22.1 Chile Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  83. 7.22.2 Chile Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  84. 7.22.3 Chile Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  85. 7.23 Colombia
  86. 7.23.1 Colombia Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  87. 7.23.2 Colombia Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  88. 7.23.3 Colombia Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  89. 7.24 Peru
  90. 7.24.1 Peru Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  91. 7.24.2 Peru Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  92. 7.24.3 Peru Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  93. 7.25 Saudi Arabia
  94. 7.25.1 Saudi Arabia Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  95. 7.25.2 Saudi Arabia Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  96. 7.25.3 Saudi Arabia Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  97. 7.26 Israel
  98. 7.26.1 Israel Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  99. 7.26.2 Israel Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  100. 7.26.3 Israel Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  101. 7.27 UAE
  102. 7.27.1 UAE Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  103. 7.27.2 UAE Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  104. 7.27.3 UAE Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  105. 7.28 Turkey
  106. 7.28.1 Turkey Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  107. 7.28.2 Turkey Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  108. 7.28.3 Turkey Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  109. 7.29 Iran
  110. 7.29.1 Iran Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  111. 7.29.2 Iran Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  112. 7.29.3 Iran Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
  113. 7.30 Egypt
  114. 7.30.1 Egypt Whole Exome Sequencing Sales Value Growth Rate (2021-2032)
  115. 7.30.2 Egypt Whole Exome Sequencing Sales Value Share by Type, 2025 VS 2032
  116. 7.30.3 Egypt Whole Exome Sequencing Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Illumina
  2. 8.1.1 Illumina Company Information
  3. 8.1.2 Illumina Business Overview
  4. 8.1.3 Illumina Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Illumina Whole Exome Sequencing Product Portfolio
  6. 8.1.5 Illumina Recent Developments
  7. 8.2 Thermo Fisher
  8. 8.2.1 Thermo Fisher Company Information
  9. 8.2.2 Thermo Fisher Business Overview
  10. 8.2.3 Thermo Fisher Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Thermo Fisher Whole Exome Sequencing Product Portfolio
  12. 8.2.5 Thermo Fisher Recent Developments
  13. 8.3 Roche
  14. 8.3.1 Roche Company Information
  15. 8.3.2 Roche Business Overview
  16. 8.3.3 Roche Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Roche Whole Exome Sequencing Product Portfolio
  18. 8.3.5 Roche Recent Developments
  19. 8.4 Angilent
  20. 8.4.1 Angilent Company Information
  21. 8.4.2 Angilent Business Overview
  22. 8.4.3 Angilent Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Angilent Whole Exome Sequencing Product Portfolio
  24. 8.4.5 Angilent Recent Developments
  25. 8.5 Eurofins
  26. 8.5.1 Eurofins Company Information
  27. 8.5.2 Eurofins Business Overview
  28. 8.5.3 Eurofins Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  29. 8.5.4 Eurofins Whole Exome Sequencing Product Portfolio
  30. 8.5.5 Eurofins Recent Developments
  31. 8.6 Sengenics
  32. 8.6.1 Sengenics Company Information
  33. 8.6.2 Sengenics Business Overview
  34. 8.6.3 Sengenics Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Sengenics Whole Exome Sequencing Product Portfolio
  36. 8.6.5 Sengenics Recent Developments
  37. 8.7 Ambry
  38. 8.7.1 Ambry Company Information
  39. 8.7.2 Ambry Business Overview
  40. 8.7.3 Ambry Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Ambry Whole Exome Sequencing Product Portfolio
  42. 8.7.5 Ambry Recent Developments
  43. 8.8 Macrogen
  44. 8.8.1 Macrogen Company Information
  45. 8.8.2 Macrogen Business Overview
  46. 8.8.3 Macrogen Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Macrogen Whole Exome Sequencing Product Portfolio
  48. 8.8.5 Macrogen Recent Developments
  49. 8.9 BGI
  50. 8.9.1 BGI Company Information
  51. 8.9.2 BGI Business Overview
  52. 8.9.3 BGI Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  53. 8.9.4 BGI Whole Exome Sequencing Product Portfolio
  54. 8.9.5 BGI Recent Developments
  55. 8.10 Novo Gene
  56. 8.10.1 Novo Gene Company Information
  57. 8.10.2 Novo Gene Business Overview
  58. 8.10.3 Novo Gene Whole Exome Sequencing Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Novo Gene Whole Exome Sequencing Product Portfolio
  60. 8.10.5 Novo Gene Recent Developments
9 Concluding Insights
    10 Appendix
    1. 10.1 Reasons for Doing This Study
    2. 10.2 Research Methodology
    3. 10.3 Research Process
    4. 10.4 Authors List of This Report
    5. 10.5 Data Source
    6. 10.5.1 Secondary Sources
    7. 10.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst